Silexion Therapeutics Corp Insider Ownership | SLXN

Insider Holdings by Owner

45.80K Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

3.67%

■0% pp QoQ

Shares Held by Insiders

43.26K

filed for Sep 2026

■0.00% QoQ

Shares Outstanding

1.18Mn

1,179,844 shares

Direct Holdings

40.72K

Indirect: 2.54K

Net Shares Traded (QoQ)

0

no net change in Sep 2026

Insiders Holding Shares

8

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 5, 2026

Across the past 12 months, open-market trades by Silexion Therapeutics insiders were all sales, totaling $31,032.

Mitchell Shirvan (CSO and CDO) led open-market sales of Silexion Therapeutics stock over the past 12 months with $31,032, most recently on March 26, 2026.
According to Business Quant data, insiders at Silexion Therapeutics reported 43.26K shares in total in their latest Form 4 filings, unchanged from 43.26K shares at the end of Q2 2026.
Of the 43.26K shares held by Silexion Therapeutics insiders, 40.72K shares (94.13%) are held directly and 2.54K shares (5.87%) indirectly, through trusts, partnerships, family members and other entities.
Holdings in Silexion Therapeutics stock are reported by 7 insiders, the officers, directors and 10% owners who have filed a Form 4 in the past two years.
SLXN's largest insider holders by reported holdings are Ilan Hadar (Chairman and CEO, 16.55K shares), Hadar Mirit Horenshtein (CFO and Secretary, 12.52K shares) and Mitchell Shirvan (CSO and CDO, 8.79K shares).
Ilan Hadar holds 38.25% of the combined insider position in Silexion Therapeutics.
Over the trailing 12 months, 8 insiders reported transactions in SLXN stock across 12 Form 4 filings.
The insider data for SLXN reflects Form 4 filings through June 8, 2026.

Form 4 Holdings

Insiders Holding SLXN

Insiders 8

Shares held 45.80K

Of outstanding 3.88%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Ilan Hadar	Chairman And Ceo	16,547	0	16,547	36.1%	08 Jun, 2026
2	Hadar Mirit Horenshtein	Cfo And Secretary	12,515	0	12,515	27.3%	08 Jun, 2026
3	Mitchell Shirvan	Cso And Cdo	8,789	0	8,789	19.2%	08 Jun, 2026
4	Shlomo Noy	Director	0	2,540	2,540	5.5%	25 Feb, 2026
5	Avner Lushi	Director	0	2,540	2,540	5.5%	23 Feb, 2026
6	Ruth Alon	Director	1,023	0	1,023	2.2%	23 Feb, 2026
7	Dror Yosef Abramov	Director	1,018	0	1,018	2.2%	23 Feb, 2026
8	Amnon Peled	Director	824	0	824	1.8%	23 Feb, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

17 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
04 Jun, 2026	Mitchell Shirvan	Cso And Cdo	Acquired A	6,000	$0.00	$0	8,789	Direct
04 Jun, 2026	Hadar Mirit Horenshtein	Cfo And Secretary	Acquired A	7,500	$0.00	$0	12,515	Direct
04 Jun, 2026	Ilan Hadar	Chairman And Ceo	Acquired A	10,000	$0.00	$0	16,547	Direct
26 Mar, 2026	Mitchell Shirvan	Cso And Cdo	Disposed S	22,818	$13.60	$310.32K	2,789	Direct
20 Feb, 2026	Shlomo Noy	Director	Acquired A	9,091	$0.00	$0	2,540	Indirect
20 Feb, 2026	Shlomo Noy	Director	Acquired A	10,685	$0.00	$0	1,069	Indirect
20 Feb, 2026	Amnon Peled	Director	Acquired A	7,576	$0.00	$0	824	Direct
20 Feb, 2026	Ilan Hadar	Chairman And Ceo	Acquired A	64,350	$0.00	$0	6,547	Direct
20 Feb, 2026	Mitchell Shirvan	Cso And Cdo	Acquired A	49,726	$0.00	$0	5,071	Direct
20 Feb, 2026	Ruth Alon	Director	Acquired A	9,091	$0.00	$0	1,023	Direct
20 Feb, 2026	Hadar Mirit Horenshtein	Cfo And Secretary	Acquired A	49,726	$0.00	$0	5,015	Direct
20 Feb, 2026	Avner Lushi	Director	Acquired A	9,091	$0.00	$0	2,540	Indirect
20 Feb, 2026	Dror Yosef Abramov	Director	Acquired A	9,091	$0.00	$0	1,018	Direct
20 Feb, 2026	Dror Yosef Abramov	Director	Acquired A	10,685	$0.00	$0	1,069	Direct
20 Feb, 2026	Ruth Alon	Director	Acquired A	10,685	$0.00	$0	1,069	Direct
20 Feb, 2026	Amnon Peled	Director	Acquired A	8,904	$0.00	$0	890	Direct
20 Feb, 2026	Avner Lushi	Director	Acquired A	10,685	$0.00	$0	1,069	Indirect

Silexion Therapeutics SLXN Insider Ownership